Literature DB >> 33644125

Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model.

Knut Asbjørn Rise Langlo1,2, Gustavo Jose Justo Silva1,3, Tina Syvertsen Overrein4, Volker Adams5, Ulrik Wisløff1,6, Håvard Dalen1,7,8, Natale Rolim1, Stein Ivar Hallan2,9.   

Abstract

There is an incomplete understanding of the underlying pathophysiology in hypertensive emergencies, where severely elevated blood pressure causes acute end-organ injuries, as opposed to the long-term manifestations of chronic hypertension. Furthermore, current biomarkers are unable to detect early end-organ injuries like hypertensive encephalopathy and renal thrombotic microangiopathy. We hypothesized that circulating microRNAs (c-miRs) could identify acute and chronic complications of severe hypertension, and that combinations of c-miRs could elucidate important pathways involved. We studied the diagnostic accuracy of 145 c-miRs in Dahl salt-sensitive rats fed either a low-salt (N = 20: 0.3% NaCl) or a high-salt (N = 60: 8% NaCl) diet. Subclinical hypertensive encephalopathy and thrombotic microangiopathy were diagnosed by histopathology. In addition, heart failure with preserved ejection fraction was evaluated with echocardiography and N-terminal pro-brain natriuretic peptide; and endothelial dysfunction was studied using acetylcholine-induced aorta ring relaxation. Systolic blood pressure increased severely in animals on a high-salt diet (high-salt 205 ± 20 mm Hg vs. low-salt 152 ± 18 mm Hg, p < 0.001). Partial least squares discriminant analysis revealed 68 c-miRs discriminating between animals with and without hypertensive emergency complications. Twenty-nine c-miRs were strongly associated with hypertensive encephalopathy, 24 c-miRs with thrombotic microangiopathy, 30 c-miRs with heart failure with preserved ejection fraction, and 28 c-miRs with endothelial dysfunction. Hypertensive encephalopathy, thrombotic microangiopathy and heart failure with preserved ejection fraction were associated with deviations in many of the same c-miRs, whereas endothelial dysfunction was associated with a different set of c-miRs. Several of these c-miRs demonstrated fair to good diagnostic accuracy for a composite outcome of hypertensive encephalopathy, thrombotic microangiopathy and heart failure with preserved ejection fraction in receiver-operating-curve analyses (area-under-curve 0.75-0.88). Target prediction revealed an enrichment of genes related to several pathways relevant for cardiovascular disease (e.g., mucin type O-glycan biosynthesis, MAPK, Wnt, Hippo, and TGF-beta signaling). C-miRs could potentially serve as biomarkers of severe hypertensive end-organ injuries and elucidate important pathways involved.
Copyright © 2021 Langlo, Silva, Overrein, Adams, Wisløff, Dalen, Rolim and Hallan.

Entities:  

Keywords:  endothelial dysfunction; heart failure with preserved ejection fraction; hypertensive emergency; hypertensive encephalopathy; microRNA; pathway prediction; thrombotic microangiopathy

Year:  2021        PMID: 33644125      PMCID: PMC7906971          DOI: 10.3389/fcvm.2020.626699

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN: 2297-055X


  86 in total

Review 1.  The pathophysiology of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

2.  miR-21: a star player in cardiac hypertrophy.

Authors:  Burcu Duygu; Paula A Da Costa Martins
Journal:  Cardiovasc Res       Date:  2015-02-02       Impact factor: 10.787

Review 3.  MicroRNAs in endothelial cell homeostasis and vascular disease.

Authors:  Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

Review 4.  Aging, MicroRNAs, and Heart Failure.

Authors:  Maria Cristina Florio; Alessandra Magenta; Sara Beji; Edward G Lakatta; Maurizio C Capogrossi
Journal:  Curr Probl Cardiol       Date:  2018-12-29       Impact factor: 5.200

Review 5.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.

Authors:  Kobina Essandoh; Yutian Li; Jiuzhou Huo; Guo-Chang Fan
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

Review 6.  Myocardial remodeling in hypertension.

Authors:  W Nadruz
Journal:  J Hum Hypertens       Date:  2014-05-08       Impact factor: 3.012

7.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

8.  Circulating microRNAs, potential biomarkers for drug-induced liver injury.

Authors:  Kai Wang; Shile Zhang; Bruz Marzolf; Pamela Troisch; Amy Brightman; Zhiyuan Hu; Leroy E Hood; David J Galas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

9.  Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.

Authors:  Omar F Laterza; Lee Lim; Philip W Garrett-Engele; Katerina Vlasakova; Nagaraja Muniappa; Wesley K Tanaka; Jason M Johnson; Joseph F Sina; Thomas L Fare; Frank D Sistare; Warren E Glaab
Journal:  Clin Chem       Date:  2009-09-10       Impact factor: 8.327

Review 10.  MicroRNAs as Diagnostic and Prognostic Biomarkers in Ischemic Stroke-A Comprehensive Review and Bioinformatic Analysis.

Authors:  Ceren Eyileten; Zofia Wicik; Salvatore De Rosa; Dagmara Mirowska-Guzel; Aleksandra Soplinska; Ciro Indolfi; Iwona Jastrzebska-Kurkowska; Anna Czlonkowska; Marek Postula
Journal:  Cells       Date:  2018-12-06       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.